PMID: 6978761Jun 1, 1982Paper

Pseudolymphoma with mycosis fungoides manifestations, hyperresponsiveness to diphenylhydantoin, and lymphocyte disregulation

Cancer
C J RosenthalS N Kapelner

Abstract

Three patients receiving diphenylhydantoin (DPH) were seen with a reversible process suggesting mycosis fungoides. Clinical and laboratory manifestations included generalized pruritic exfoliative erythroderma, eosinophilia, lymphadenopathy, hepatosplenomegaly, circulating Sézary cells, epidermal Pautrier's microabscesses on skin biopsy, and moderate liver dysfunction. Studies of the distribution and function of the various lymphocyte subpopulations from these patients showed: (1) an increase in the relative and absolute number of T lymphocytes (85--92%); (2) significant stimulation of lymphocyte-blastic transformation by DPH and low response to pokeweed mitogen stimulation; (3) the impaired ability of T gamma lymphocytes to suppress B-cell differentiation and immunoglobulin production. With only one exception, 15 symptom-free patients on DPH showed none of these abnormalities. The clinical manifestations and immunologic abnormalities of patients with this pseudo mycosis fungoides syndrome remitted three to four weeks after DPH administration was discontinued. The proliferation of T lymphocytes and the inhibition of the function of T gamma-suppressor lymphocytes noted in these patients may be significant to the development of ot...Continue Reading

References

Nov 1, 1978·The Journal of Pediatrics·A CoppolaJ Sher
May 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·D Zucker-FranklinF Quagliata
Sep 1, 1968·Annals of Internal Medicine·R A GamsF G Conrad
May 1, 1970·Archives of Neurology·J J Anthony
Jun 20, 1964·Lancet·P HOLLAND, A M MAUER

❮ Previous
Next ❯

Citations

Oct 1, 1994·Journal of Clinical Pharmacology·D K SunS Luftschein
Mar 1, 1989·Journal of Neurology·N E Gilhus, T Lea
Jun 1, 2000·Clinical Reviews in Allergy & Immunology·P Wolkenstein, J Revuz
Dec 1, 1994·International Journal of Immunopharmacology·N BaşaranA Ciğer
Apr 1, 1988·Journal of the American Academy of Dermatology·A K SilvermanR C Wong
Jun 12, 2004·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Rachel E Story, Anne Marie Ditto
May 12, 1998·British Journal of Haematology·A Jabbar, T Siddique
Nov 10, 1994·The New England Journal of Medicine·J C Roujeau, R S Stern
May 1, 1995·Indian Journal of Dermatology, Venereology and Leprology·C Balachandran
Apr 1, 1992·Clinical Otolaryngology and Allied Sciences·G Grillone, D Myssiorek
Apr 1, 1990·Journal of Cutaneous Pathology·S WelykyjM Massa
Nov 2, 1999·Acta Clinica Belgica·S Tas, T Simonart
Oct 27, 2004·Expert Opinion on Drug Safety·Noah Scheinfeld
Feb 11, 2015·Epilepsy & Behavior Case Reports·İbrahim BoraŞaduman Balaban
Feb 1, 1991·Journal of the American Academy of Dermatology·U RijlaarsdamR Willemze
Dec 20, 2007·American Journal of Clinical Pathology·Katalin KelemenLoann C Peterson
Mar 1, 1986·Journal of the American Academy of Dermatology·S C van der PutteW A van Vloten
Jan 1, 1989·Journal of the American Academy of Dermatology·G F Oliver, R K Winkelmann
Jan 1, 1988·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·E S Helmy, R Tripplet
Jul 30, 2009·Journal of Cutaneous Pathology·Ossama Abbas, Jag Bhawan
Mar 1, 1995·Journal of the American Academy of Dermatology·C M Magro, A N Crowson
Oct 1, 1989·The Journal of Dermatology·K DannoY Kobashi
Feb 1, 1996·Journal of the American Academy of Dermatology·K B GordonS Rosen
Jan 1, 1993·Clinical Oncology : a Journal of the Royal College of Radiologists·J SingerP G Isaacson
Apr 1, 1988·The British Journal of Dermatology·S H KardaunB J Vermeer
Mar 1, 1994·International Journal of Dermatology·C M Magro, A N Crowson
Jan 1, 1989·The Australasian Journal of Dermatology·G F OliverP M Banks
Jan 18, 2006·Journal of Cutaneous Pathology·Eric C Vonderheid
Apr 12, 2003·Journal of Cutaneous Pathology·Sandra H ClarkVictor G Prietol
Sep 1, 1991·DICP : the Annals of Pharmacotherapy·P A HowardM I Dunn
Jul 30, 2002·Cardiology in Review·William H FrishmanAnd Diana K Sun

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved